MeSH Review:
Orthopoxvirus
Baker,
Bray,
Huggins,
Müllbacher,
Hla,
Museteanu,
Simon,
Buller,
Owens,
Schriewer,
Melman,
Beadle,
Hostetler,
Smee,
Sidwell,
Kefauver,
Bray,
Huggins,
Sejvar,
Chowdary,
Schomogyi,
Stevens,
Patel,
Karem,
Fischer,
Kuehnert,
Zaki,
Paddock,
Guarner,
Shieh,
Patton,
Bernard,
Li,
Olson,
Kline,
Loparev,
Schmid,
Beard,
Regnery,
Damon,
Smith,
- Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Symons, J.A., Alcamí, A., Smith, G.L. Cell (1995)
- Virus proteins that bind cytokines, chemokines or interferons. Smith, G.L. Curr. Opin. Immunol. (1996)
- Interferon function is not required for recovery from a secondary poxvirus infection. Panchanathan, V., Chaudhri, G., Karupiah, G. Proc. Natl. Acad. Sci. U.S.A. (2005)
- A protein phosphatase related to the vaccinia virus VH1 is encoded in the genomes of several orthopoxviruses and a baculovirus. Hakes, D.J., Martell, K.J., Zhao, W.G., Massung, R.F., Esposito, J.J., Dixon, J.E. Proc. Natl. Acad. Sci. U.S.A. (1993)
- Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Macen, J.L., Garner, R.S., Musy, P.Y., Brooks, M.A., Turner, P.C., Moyer, R.W., McFadden, G., Bleackley, R.C. Proc. Natl. Acad. Sci. U.S.A. (1996)
- A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Alcamí, A., Smith, G.L. Cell (1992)
- A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Alejo, A., Ruiz-Argüello, M.B., Ho, Y., Smith, V.P., Saraiva, M., Alcami, A. Proc. Natl. Acad. Sci. U.S.A. (2006)
- A third distinct tumor necrosis factor receptor of orthopoxviruses. Loparev, V.N., Parsons, J.M., Knight, J.C., Panus, J.F., Ray, C.A., Buller, R.M., Pickup, D.J., Esposito, J.J. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Poxvirus-induced alteration of arachidonate metabolism. Palumbo, G.J., Glasgow, W.C., Buller, R.M. Proc. Natl. Acad. Sci. U.S.A. (1993)
- Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism. Aldern, K.A., Ciesla, S.L., Winegarden, K.L., Hostetler, K.Y. Mol. Pharmacol. (2003)
- Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. Kotwal, G.J., Moss, B. J. Virol. (1989)
- An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. Yang, G., Pevear, D.C., Davies, M.H., Collett, M.S., Bailey, T., Rippen, S., Barone, L., Burns, C., Rhodes, G., Tohan, S., Huggins, J.W., Baker, R.O., Buller, R.L., Touchette, E., Waller, K., Schriewer, J., Neyts, J., DeClercq, E., Jones, K., Hruby, D., Jordan, R. J. Virol. (2005)
- Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. Turner, P.C., Moyer, R.W. J. Virol. (1995)
- Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses. Beadle, J.R., Wan, W.B., Ciesla, S.L., Keith, K.A., Hartline, C., Kern, E.R., Hostetler, K.Y. J. Med. Chem. (2006)
- Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. Colamonici, O.R., Domanski, P., Sweitzer, S.M., Larner, A., Buller, R.M. J. Biol. Chem. (1995)
- Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. McIntosh, A.A., Smith, G.L. J. Virol. (1996)
- Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Smee, D.F., Sidwell, R.W., Kefauver, D., Bray, M., Huggins, J.W. Antimicrob. Agents Chemother. (2002)
- Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Baker, R.O., Bray, M., Huggins, J.W. Antiviral Res. (2003)
- Analysis of the nucleotide sequence of 48 kbp of the variola major virus strain India-1967 located on the right terminus of the conservative genome region. Shchelkunov, S.N., Resenchuk, S.M., Totmenin, A.V., Blinov, V.M., Sandakhchiev, L.S. Virus Res. (1994)
- Interferon- gamma -Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by gamma delta T Cells. Agrati, C., Castilletti, C., De Santis, R., Cimini, E., Bordi, L., Malkovsky, M., Poccia, F., Capobianchi, M.R. J. Infect. Dis. (2006)
- Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication. Palumbo, G.J., Buller, R.M. Virology (1991)
- Mapping and molecular characterization of a functional thymidine kinase from Amsacta moorei entomopoxvirus. Gruidl, M.E., Hall, R.L., Moyer, R.W. Virology (1992)
- Analysis of the camelpox virus thymidine kinase gene. Binns, M., Mumford, J., Wernery, U. Br. Vet. J. (1992)
- Soluble interferon-gamma receptors encoded by poxviruses. Alcamí, A., Smith, G.L. Comp. Immunol. Microbiol. Infect. Dis. (1996)
- The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Turner, P.C., Baquero, M.T., Yuan, S., Thoennes, S.R., Moyer, R.W. Virology (2000)
- Perforin is essential for control of ectromelia virus but not related poxviruses in mice. Müllbacher, A., Hla, R.T., Museteanu, C., Simon, M.M. J. Virol. (1999)
- Human monkeypox infection: a family cluster in the midwestern United States. Sejvar, J.J., Chowdary, Y., Schomogyi, M., Stevens, J., Patel, J., Karem, K., Fischer, M., Kuehnert, M.J., Zaki, S.R., Paddock, C.D., Guarner, J., Shieh, W.J., Patton, J.L., Bernard, N., Li, Y., Olson, V.A., Kline, R.L., Loparev, V.N., Schmid, D.S., Beard, B., Regnery, R.R., Damon, I.K. J. Infect. Dis. (2004)
- Belo Horizonte virus: a vaccinia-like virus lacking the A-type inclusion body gene isolated from infected mice. Trindade, G.S., da Fonseca, F.G., Marques, J.T., Diniz, S., Leite, J.A., De Bodt, S., Van der Peer, Y., Bonjardim, C.A., Ferreira, P.C., Kroon, E.G. J. Gen. Virol. (2004)
- Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Buller, R.M., Owens, G., Schriewer, J., Melman, L., Beadle, J.R., Hostetler, K.Y. Virology (2004)
- Characterization of antibodies to orthopoxviruses in human sera by radioimmunoassay. Walls, H.H., Ziegler, D.W., Nakano, J.H. Bull. World Health Organ. (1981)
- Ocular complications of smallpox vaccination. Pepose, J.S., Margolis, T.P., LaRussa, P., Pavan-Langston, D. Am. J. Ophthalmol. (2003)